VCYT Chart
- 52-Week Range: $15.45 - $53.79
- Market Capitalization: $1.31B
- Short Percentage: 0%
- Target Price: $30.67
- Shares Outstanding: 71.45M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
VCYT released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Veracyte, Inc. (VCYT) CEO Marc Stapley on Q1 2022 Results - Earning Calls TranscriptSeeking Alpha | May 3rd
- Veracyte, Inc. (VCYT) CEO Marc Stapley on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | February 28th
- Veracyte to Release Fourth Quarter and Full-Year 2021 Financial Results on February 28, 2022Business Wire | February 15th
- Veracyte to Participate in 11th Annual SVB Leerink Global Healthcare ConferenceBusiness Wire | February 8th
- Veracyte Announces New Data to be Presented at the 2022 ASCO Genitourinary (GU) Cancers SymposiumBusiness Wire | January 31st
- Veracyte Announces Key Leadership Promotions to Advance Its Strategic Global VisionBusiness Wire | January 6th
- Best Long Term Stocks To Buy? 4 Health Care Stocks For Your WatchlistStockmarketcom | December 21st
Company Info
Website: https://www.veracyte.com
Address: 6000 Shoreline Court, South San Francisco, CA, United States, 94080
Sector: Healthcare
Industry: Biotechnology
Full time employees: 761
Address: 6000 Shoreline Court, South San Francisco, CA, United States, 94080
Sector: Healthcare
Industry: Biotechnology
Full time employees: 761
$VCYT bought more
$VCYT out of the way
$VCYT oversold! Buy the dip
$VCYT what happen
$VCYT I blocked some bears and I liked it!
$VCYT wtf is going on?
$VCYT very nice
$VCYT See ya Monday
$VCYT Bears go home!